• Skip to main content
  • Skip to footer
  • UCI
  • Office of the Provost
  • Academic Initiatives
Donate
Follow IDSI on Twitter!
id science logo
  • Research
  • Publications
  • About Us
    • Leadership & Staff
    • Faculty Advisory Board
    • Affiliate Faculty
    • Contact Us
  • News
  • Events
  • Education & Training
  • Funding Opportunities
  • Resources
    • Coronavirus Disease (COVID-19) Outbreak Resources

🥼Rates of individual HIV mutations, and clinically relevant transmitted drug resistance are low.

You are here: Home / News & Announcements / 🥼Rates of individual HIV mutations, and clinically relevant transmitted drug resistance are low.

January 11, 2023

Rates of both individual mutations and clinically relevant transmitted drug resistance were low among people newly diagnosed with HIV who were not previously on ART, according to a recent study.

“There is a lack of updated info on transmitted drug resistance in Europe — and in the rest of the world — and there is an interest in knowing how transmitted drug resistance (TDR) may impact the use of first-line regimens to treat HIV infection, specifically if the prevalence of TDR may justify a need to wait for a resistance test before first-line treatment,” Federico García, PharmD, PhD, vice president of the Spanish Society of Infectious Diseases and Clinical Microbiology, told Healio.

García and colleagues used data from MeditRes HIV — a consortium that includes ART-naive people with HIV who have been newly diagnosed in France, Greece, Italy, Portugal, and Spain between 2018 and 2021. According to the study, the researchers assessed reverse transcriptase and integrase (INSTI) sequences provided by participating centers to evaluate the prevalence of surveillance drug resistance mutations (SDRMs) and clinically relevant resistance (CRR).

Read More

News & Announcements,  Research

Footer

Coronavirus Disease (COVID-19) Outbreak Resources

COVID-19

Resources

medical technology

Research

map of the world

Publications

magnifying glass
Get In Touch!

Office of Academic Planning
535 Aldrich Hall
University of California, Irvine
Irvine, CA 92697-1000

idinitiative@uci.edu

 

 

About Us

UCI Infectious Disease Science Initiative aims to position UCI as a global leader in research and education in infectious disease dynamics by fueling the development of new knowledge and insights into the dynamics of infectious diseases and drug resistance.

© 2019 UC Regents  |  Privacy Policy